Central Hospital, Nancy, France: Infections trials

The registry lists 13 Infections studies with Central Hospital, Nancy, France as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 4 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus BacteremiaActive, not recruitingNCT07186894
• Pseudomonas Aeruginosa Infections Among COVID-19 Patients in Intensive Care Units at CHRU of Nancy (Pyo-COVID-3)CompletedNCT06141837
• Diagnosis of Congenital Cytomegalovirus Infection in Newborn With Particular RiskCompletedNCT05754879
• Evaluating Antibiotic Stewardship Assisted by Computer in the University Hospital of Nancy (MACABAO)Status unknownNCT04976829
• Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular DysfunctionStatus unknownNCT04937712
• Tracheobronchitis in Respiratory Involvement on the Lung SPECT/CT Images of Coronavirus Disease (COVID-19) PatientsCompletedNCT04629222
• Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care UnitCompletedNCT04528043
• Assessment of Diagnostic and Therapeutic Practices for Cardiac Implantable Electronic Devices Suspected Infections in Nancy University HospitalCompletedNCT04501835
• FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 ContextStatus unknownNCT04453540
• Environmental Risk Factors of Mesh Infection After Abdominal Wall Hernia RepairStatus unknownNCT04174976
• Selective Reporting of Antibiotic Susceptibility Test Results in Urinary Tract Infections in the Outpatient SettingStatus unknownNCT03612297
• Hepatitis E Infection : Emergence Mechanisms in North-Eastern France of Polymorphic Clinical Forms.Status unknownNCT03524014
• Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia ColiTerminatedNCT02474706Phase 4